ROSEN, A LEADING LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – VERVGlobeNewsWire • 10/11/24
Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law FirmAccesswire • 10/11/24
Levi & Korsinsky Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming DeadlineAccesswire • 10/11/24
Verve Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - VERVPRNewsWire • 10/11/24
VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/10/24
The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming DeadlinePRNewsWire • 10/10/24
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics, Inc. Lawsuit – VERVGlobeNewsWire • 10/09/24
Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law FirmAccesswire • 10/09/24
VERV STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/09/24
Verve Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights – VERVAccesswire • 10/08/24
The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc. (VERV) of a Class Action Lawsuit and an Upcoming DeadlineGlobeNewsWire • 10/08/24
The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Verve Therapeutics, Inc.Accesswire • 10/08/24
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Verve Therapeutics, Inc. (VERV) ShareholdersAccesswire • 10/08/24
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – VERVGlobeNewsWire • 10/08/24
VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/08/24
Verve Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - VERVAccesswire • 10/07/24
VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/07/24
VERV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/06/24
VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff DeadlineGlobeNewsWire • 10/05/24
ROSEN, LEADING INVESTOR COUNSEL, Encourages Verve Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – VERVGlobeNewsWire • 10/03/24
Verve Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Reach Out To The Schall Law FirmAccesswire • 10/03/24
Verve Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – VERVAccesswire • 10/02/24
Shareholders that lost money on Verve Therapeutics, Inc. (VERV) should contact The Gross Law Firm about pending Class Action - VERVGlobeNewsWire • 10/02/24
The Schall Law Firm Seeks Investor Participation In A Securities Fraud Case Against Verve Therapeutics, Inc.Accesswire • 10/02/24
VERV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Verve Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!Accesswire • 10/02/24